Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12611451 | Neisseria meningitidis vaccine | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12611290 | Method for forming and polishing a composite denture | 🖼🧊📄§ | 2026-04-28 | 2044-08-21 | 0 | 31 |
| 12612343 | PSMA binder and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-04-13 | 0 | 31 |
| 12611408 | Methods for treating nail brittleness, fragility, or pitting | 🖼🧊📄§ | 2026-04-28 | 2039-06-04 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611467 | APOE gene therapy | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12611442 | mRNA encoding engineered CFTR | 🖼🧊📄§ | 2026-04-28 | 2040-09-17 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611454 | Recombinant vaccine against COVID-19 based on a paramyxovirus viral vector | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611419 | Liposomal composition for use in a method of treating Parkinson's disease | 🖼🧊📄§ | 2026-04-28 | 2043-03-09 | 0 | 31 |
| 12611432 | Immunostimulatory bacteria for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2043-07-11 | 0 | 31 |
| 12611286 | Method and apparatus for dental crown restorations using prefabricated sleeve-crown pairs | 🖼🧊📄§ | 2026-04-28 | 2042-08-19 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12612461 | Single domain antibodies against CLL-1 | 🖼🧊📄§ | 2026-04-28 | 2039-11-27 | 0 | 31 |
| 12612384 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | 🖼🧊📄§ | 2026-04-28 | 2042-05-04 | 0 | 31 |
| 12612358 | Resorcinol-based compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-16 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12611410 | Emulsion, injection agent, and emulsion preparation method | 🖼🧊📄§ | 2026-04-28 | 2041-04-15 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12612602 | Production of a bioengineered lung | 🖼🧊📄§ | 2026-04-28 | 2039-04-18 | 0 | 31 |
| 12612637 | Compositions and methods for DHFR tunable protein regulation | 🖼🧊📄§ | 2026-04-28 | 2040-09-04 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12611415 | Methods and compounds for treatment of metabolic disease | 🖼🧊📄§ | 2026-04-28 | 2040-09-21 | 0 | 31 |
| 12611427 | Treatment of NSCLC patients refractory for anti-PD-1 antibody | 🖼🧊📄§ | 2026-04-28 | 2039-11-04 | 0 | 31 |
| 12612406 | Cytisine salts | 🖼🧊📄§ | 2026-04-28 | 2042-07-29 | 0 | 31 |
| 12611424 | Cosmetic/dermatological composition | 🖼🧊📄§ | 2026-04-28 | 2039-12-30 | 0 | 31 |
| 12611383 | Pharmaceutical compositions for treating MCT8 deficiency | 🖼🧊📄§ | 2026-04-28 | 2045-07-07 | 0 | 31 |
| 12612429 | Derivatives of dolaproine-dolaisoleuine peptides | 🖼🧊📄§ | 2026-04-28 | 2042-03-18 | 0 | 31 |
| 12611455 | DNA nanostructure-based vaccines | 🖼🧊📄§ | 2026-04-28 | 2040-06-05 | 0 | 31 |
| 12611405 | Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2038-03-28 | 0 | 31 |
| 12611441 | PSMA specific binding proteins for cancer diagnosis and treatment | 🖼🧊📄§ | 2026-04-28 | 2040-04-08 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12612420 | Arginase inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-22 | 0 | 31 |
| 12612457 | Humanized antibodies against Nectin-2 and drug conjugates thereof | 🖼🧊📄§ | 2026-04-28 | 2044-08-28 | 0 | 31 |
| 12612597 | Methods for preparing therapeutically active cells using microfluidics | 🖼🧊📄§ | 2026-04-28 | 2041-09-06 | 0 | 31 |
| 12612438 | Bistable type II opsins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-09-19 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12612635 | BCMA-binding single variable structural domain and antigen-binding molecule | 🖼🧊📄§ | 2026-04-28 | 2041-08-16 | 0 | 31 |
| 12612444 | T cell receptors targeting mutations in RNA splicing factors | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611372 | Strain and use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-12-13 | 0 | 31 |
| 12611401 | Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases | 🖼🧊📄§ | 2026-04-28 | 2040-05-15 | 0 | 31 |
| 12611438 | Antiviral composition comprising a nucleolin-binding peptide | 🖼🧊📄§ | 2026-04-28 | 2042-05-18 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611434 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | 🖼🧊📄§ | 2026-04-28 | 2043-06-21 | 0 | 31 |
| 12611445 | Interleukin-2 variants with modified biological activity | 🖼🧊📄§ | 2026-04-28 | 2040-03-27 | 0 | 31 |